Case File
efta-efta00966384DOJ Data Set 9OtherDS9 Document EFTA00966384
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00966384
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: Jeffrey Epstein <[email protected]>
Subject: Re: visa
Date: Sun, 04 Aug 2013 16:00:02 +0000
I don't know how else to explain it.. ?
Aviloop. As payment for services, to show income for the visa. It should have been done 2months ago because
they want bank statements for the last 3 months.
Sent from my iPhone
On Aug 4, 2013, at 8:40 AM, Jeffrey Epstein <[email protected]> wrote:
a wire transfer ? to who, what. . you personally. ?
On Sat, Aug 3, 2013 at 5:22 PM,
> wrote:
Fund. Bank statements. Income.
I need to show money in the bank & more income than just what's necessary to support one person. All I
need from you to be able to move forward and come up with all other paperwork is a wire transfer.
Sent from my iPad
On Aug 2, 2013, at 8:40 PM, Jeffrey Epstein <[email protected]> wrote:
intemet has been out, i don't understand what this means. what do you need to submit, do you need tax
returns, biz returns, . what is the appeal process. ? what do you want exactly. you mention evidence.of
other sources? not sure what you want.
On Wed, Jul 31, 2013 at 10:31 PM,
> wrote:
I talked to my lawyer and I need to really get the application ready asap. 100k should be ok to satisfy the
requirement that the E-2 enterprise generate income substantially above what would be considered a
living. They also want evidence that the E-2 investor has other sources of income (income from real
estate properties, investments etc.), which could have been wired to a bank account in Slovakia.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
EFTA00966384
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in en-or, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00966385
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.